Kenai Therapeutics
Kenai Therapeutics is a biotech company in San Diego, United States, founded in 2022. It has raised $90.0M across 2 rounds, most recently an $8.0M Grant in January 2026.
Pioneering next generation approaches to cure neurological conditions.
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2022
- Website
- kenaitx.com
- Total Funding
- $90.0M
- Last Round
- $8.0M GrantJan 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Kenai Therapeutics is a clinical-stage biotechnology company developing off-the-shelf dopamine-neuron replacement cell therapies and gene-modified medicines for neurological conditions. Its programs aim to provide disease-modifying or potentially curative treatments that go beyond symptom management for neurodegenerative disease. The company focuses on restoring function and quality of life through next-generation approaches to neuron replacement and neurological-cell therapy.
Summary
It lists 11–50 employees. It has raised $90.0M in total across 2 rounds, most recently a $8.0M Grant round in Jan 2026. Investors include Alaska Permanent Fund, Cure Ventures and The Column Group.
Funding History
Jan 2026
Sign up to see all 2 events
Funding: Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kenai-therapeutics"><img src="https://indexed.vc/api/badge/company/kenai-therapeutics" alt="Kenai Therapeutics on Indexed.vc" width="260" height="76" /></a>
